Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide for Chronic Low Back Pain and Obesity
NCT07731256Phase 2Not yet recruiting
- Sponsor
- Washington University School of Medicine
- Start
- Feb 2027
- Primary completion
- Jan 2031
- Countries
- 1
01
Overview
A Phase 2 trial of semaglutide in chronic low back pain (CLBP), sponsored by Washington University School of Medicine. Planned start Feb 2027; status: not yet recruiting.
02
Drugs
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT07731256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07731256.